AI Article Synopsis
- Acne fulminans (AF) is a severe and rare form of acne that can come with systemic symptoms and is hard to treat.
- A case study discusses a 12-year-old boy who developed isotretinoin-induced AF (IIAF) and did not respond to standard treatments like oral steroids and isotretinoin.
- The boy was successfully treated with adalimumab, suggesting it could be an effective off-label treatment option for resistant cases of IIAF in children.
Article Abstract
Acne fulminans (AF) is a rare, acute, and severe form of acne vulgaris often associated with systemic symptoms. Its treatment is challenging and controversial. We report a case of isotretinoin-induced AF (IIAF) in a 12-year-old boy resistant to traditional therapies (oral steroids and isotretinoin). The patient was successfully treated with adalimumab that can be considered an effective off-label option in the treatment of resistant IIAF in children.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991494 | PMC |
| http://dx.doi.org/10.1159/000512032 | DOI Listing |
Publication Analysis
Top Keywords
acne fulminans
8
report case
8
adalimumab management
4
management isotretinoin-induced
4
isotretinoin-induced acne
4
fulminans report
4
case acne
4
fulminans rare
4
rare acute
4
acute severe
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!